Growing need to eradicate malaria through diagnosis and treatment is expected to fuel market growth.
Growing need to eradicate malaria through diagnosis and treatment is expected to fuel market growth.
The global malaria diagnostics market size is expected to reach USD 1.1 billion in 2028, registering a CAGR of 6% over the forecast period, according to the latest report by Reports and Data. Major factor driving market revenue growth is the need to eradicate malaria as disease through diagnosis and treatment. Malaria is one of the most prevalent life-threatening diseases, affecting tropical and subtropical regions as a result of shifting climates, low economic development, underdeveloped healthcare facilities, and lack of advanced treatment.
According to the World Health Organization (WHO), in 2019, nealy 229 million cases of malaria were recorded worldwide, with 94% of these cases occurring in the the Africa region.
In 2019, there were around 409,000 malaria deaths worldwide. Children aged under 5 years are the most vulnerable group affected by malaria as they accounted for 67% of all malaria deaths worldwide in 2019. About 95% of global malaria deaths in 2019 were concentrated in 31 countries. Nigeria, the Democratic Republic of the Congo, the United Republic of Tanzania, Mozambique, Niger and Burkina Faso accounted for about 51% of all malaria deaths globally in the same year.
Since 2010, WHO guidelines have recommended that all suspected malaria cases undergo a confirmatory test with microscopy or a Rapid Diagnostic Test (RDT) and this recommendation has been promoted by WHO’s “test, treat, and monitor” strategy since 2012. Despite the fact that malaria remains a public health problem with over 300,000 children under the age of five dying each year, recent control efforts have significantly reduced the disease burden, especially in high-transmission areas of Africa. On the other hand, introduction of RDT technology has driven the change in policy to confirmatory testing allowing for malaria diagnosis in remote and resource-poor environments and driving malaria diagnosis market.
Rising demand for malaria diagnosis and treatment in Asia Pacific and Latin America will also fuel market expansion. According to a recent UNITAID article, over 400 million malaria rapid diagnostic test treatments will be needed over the next three years to eradicate global malaria prevalence.
Malaria’s significant effect on global health has resulted in technological advancements in its diagnosis. The acceptance rate of alternative diagnostics approaches with superior efficiency and reliable diagnostic solutions has increased significantly. Rising demand for accurate malaria diagnosis would also contribute to the industry’s future growth.
In developing countries, lack of awareness about the availability of malaria diagnostics may restrain the market growth to some extent during the forecast period. Furthermore, currently available diagnostic tests are obsolete, posing a barrier to the implementation of new technology-based diagnostic tests.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/4058
Some Key Highlights in the Report:
- The microscopy segment is expected to register largest market share due to the technique’s intermittent use for diagnosis.
- Rapid diagnostic tests segment accounted for a considerable share in the malaria diagnostics market in 2020, owing to the advantages associated with their use in diagnosis of malaria.
- The clinics segment of the malaria diagnostics market accounted for the largest market share among other end user segments in 2020.
- The revenue from Africa diagnostics market is expected to grow at a significantly high rate over the forecast period.
- Asia Pacific region is expected to hold considerable revenue share due to ongoing technological research and development activities in the field of malaria diagnostics.
- Some of the prominent players in the malaria diagnostics market include Abbott, Access Bio, bioMérieux SA., Bio-Rad Laboratories, Inc., Danaher (Beckman Coulter), Novartis AG, Premier Medical Corporation, Siemens Healthineers and Thermo Fisher Scientific.
Buy now your Exclusive copy of Report @ https://www.reportsanddata.com/checkout-form/4058
Segments covered in the report:
For the purpose of this report, Reports and Data has segmented the global malaria diagnostics market on the basis of technology, end user and region:
Technology Outlook (Revenue, USD Million; 2018 – 2028)
- Microscopy
- Rapid Diagnostic Tests (RDTs)
- Molecular Diagnostic Tests
- Conventional PCR
- Real-Time PCR (qPCR)
End-user Outlook (Revenue, USD Million; 2018 – 2028)
- Hospital
- Clinics
- Diagnostic Centres
Request for Custom Research @ https://www.reportsanddata.com/request-customization-form/4058
Regional Outlook (Revenue, USD Million, 2018 – 2028)
- Africa
- Nigeria
- Democratic Republic of Congo
- Uganda
- Southeast Asia
- India
- Myanmar
- Indonesia
- Eastern Mediterranean
- Saudi Arabia
- Pakistan
- Western Pacific
- China
- Papua New Guinea
- Cambodia
- Americas
- Venezuela
- Brazil
- Colombia
- Europe
- Turkey
- France
- U.K.
- Germany
Explore Reports and Data’s Prime Analysis of the global Pharmaceutical & Healthcare Industry:
Paper Diagnostics Market Size, Share, Demand By Application (Clinical Diagnostics, Food Quality Testing), By Product Type (Lateral Flow Assays, Paper Based Microfluidics), By End-Use Verticals (Hospitals & Clinics, Diagnostics Centers, Research Institutes, Home Healthcare), Forecasts To 2027
Filter Integrity Test Market By Test Type (Bubble Point Test, Diffusion Test, Water Flow Integrity Test), By Filter Type (Air, Liquid), By Mechanism (Manual, Automated), By Industry Vertical (Pharmaceutical & Biopharmaceutical, Food & Beverage, Others), 2017-2027
Infectious Disease Diagnostics Market Size, Share And Industry Analysis By Product Type (Consumables, Instruments & analyzers, Software & services), By Technology (Traditional diagnostic technique, Molecular diagnostic technique), By Disease Type (Hepatitis, Hospital-Acquired Infections (HAIS), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG), Influenza, Human Papillomavirus, Others), By End-user (Reference Laboratories, Hospital/Clinical Laboratories, Academic/Research Institutes, Physician Offices, Others) And Region, Segment Forecasts To 2027
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Read Full Press Release: https://www.reportsanddata.com/press-release/global-malaria-diagnostics-market